Abstract:NanoLuc (NLuc) luciferase has found extensive application in designing a range of biological assays, including gene expression analysis, protein-protein interaction, and protein conformational changes due to its enhanced brightness and small size. However, questions related to its mechanism of interaction with the substrate, furimazine, as well as bioluminescence activity remain elusive. Here, we combined molecular dynamics (MD) simulation and mutational analysis to show that the R162A mutation results in a decreased but stable bioluminescence activity of NLuc in living cells and in vitro. Specifically, we performed multiple, all-atom, explicit solvent MD simulations of the apo and furimazine-docked (holo) NLuc structures revealing differential dynamics of the protein in the absence and presence of the ligand. Further, analysis of trajectories for hydrogen bonds (H-bonds) formed between NLuc and furimazine revealed substantial H-bond interaction between R162 and Q32 residues. Mutation of the two residues in NLuc revealed a decreased but stable activity of the R162A, but not Q32A, mutant NLuc in live cell and in vitro assays performed using lysates prepared from cells expressing the proteins and with the furimazine substrate. In addition to highlighting the role of the R162 residue in NLuc activity, we believe that the mutant NLuc will find wide application in designing in vitro assays requiring extended monitoring of NLuc bioluminescence activity. SIGNIFICANCE: Bioluminescence has been extensively utilized in developing a variety of biological and biomedical assays. In this regard, engineering of brighter bioluminescent proteins, i.e. luciferases, has played a significant role. This is acutely exemplified by the engineering of the NLuc luciferase, which is small in size and displays much enhanced bioluminescence and thermal stability compared to previously available luciferases. While enhanced bioluminescent activity is desirable in a multitude of biological and biomedical assays, it would also be useful to develop variants of the protein that display a prolonged bioluminescence activity. This is specifically relevant in designing assays that require bioluminescence for extended periods, such as in the case of biosensors designed for monitoring slow enzymatic or cellular signaling reactions, without necessitating multiple rounds of luciferase substrate addition or any specialized reagents that result in increased assay costs. In the current manuscript, we report a mutant NLuc that possesses a stable and prolonged bioluminescence activity, albeit lower than the wild-type NLuc, and envisage a wider application of the mutant NLuc in designing biosensors for monitoring slower biological and biomedical events.

Quantitative Measurement of Cell Membrane Receptor Internalization by the Nanoluciferase Reporter: Using the G Protein-Coupled Receptor RXFP3 As a Model

Fluorescence Biomembrane Force Probe: Concurrent Quantitation of Receptor-ligand Kinetics and Binding-induced Intracellular Signaling on a Single Cell

Imaging GPCR Internalization Using Near-Infrared Nebraska Red-Based Reagents

Multiplex Detection of Fluorescent Chemokine Binding to CXC Chemokine Receptors by NanoBRET

REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors

Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays

Real‐Time Quantification of Cell Internalization Kinetics by Functionalized Bioluminescent Nanoprobes

Endogenous Promotor-Driven Split Nanoluciferase Biosensor for Assessing G Protein Recruitment

Engineered Amber-Emitting Nano Luciferase and Its Use for Immunobioluminescence Imaging In Vivo

Label-Free Quantification of Molecular Interaction in Live Red Blood Cells by Tracking Nanometer Scale Membrane Fluctuations.

Glycoprotein-glycoprotein receptor binding detection using bioluminescence resonance energy transfer

Evaluation of NanoLuc substrates for bioluminescence imaging of transferred cells in mice

Fluorophore-NanoLuc BRET Reporters Enable Sensitive in Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis.

Real-time Endocytosis Imaging As a Rapid Assay of Ligand-Gpcr Binding in Single Cells

Expression, Purification and Characterization of Nano Luciferase in Escherichia coli

Abstract 1957: Novel substrates for NanoLuc luciferase with improved brightness and signal duration for bioluminescence imagingin vivo

Quantitative dynamics of intracellular NMN by genetically encoded biosensor

Red‐Shifted Bioluminescence Using Substrate‐Fluorophore Conjugates

A slow but steady nanoLuc: R162A mutation results in a decreased, but stable, nanoLuc activity

Simple Fluorescence Labeling Method Enables Detection of Intracellular Distribution and Expression Level of Retinoid X Receptors

Luciferase reporter assay for unlocking ligand-mediated signaling of GPCRs